Clinical treatment of advanced synchronous triple primary malignancies: comprehensive treatment based on targeted therapy

Ying Zhang, Yunjie Ge, Xiaohui Wu, Shuangmei LiuDepartment of Internal Medicine, Municipal Hospital, Qingdao, Shandong, People’s Republic of ChinaAbstract: The prevalence of cancer remains high. With the improvement of diagnosis and treatment level and the increase of cancer survivors afte...

Full description

Bibliographic Details
Main Authors: Zhang Y, Ge Y, Wu X, Liu S
Format: Article
Language:English
Published: Dove Medical Press 2019-04-01
Series:OncoTargets and Therapy
Subjects:
Online Access:https://www.dovepress.com/clinical-treatment-of-advanced-synchronous-triple-primary-malignancies-peer-reviewed-article-OTT
id doaj-20366fa36d574350b1b8acea3a26ed46
record_format Article
spelling doaj-20366fa36d574350b1b8acea3a26ed462020-11-25T01:49:05ZengDove Medical PressOncoTargets and Therapy1178-69302019-04-01Volume 122421243044887Clinical treatment of advanced synchronous triple primary malignancies: comprehensive treatment based on targeted therapyZhang YGe YWu XLiu SYing Zhang, Yunjie Ge, Xiaohui Wu, Shuangmei LiuDepartment of Internal Medicine, Municipal Hospital, Qingdao, Shandong, People’s Republic of ChinaAbstract: The prevalence of cancer remains high. With the improvement of diagnosis and treatment level and the increase of cancer survivors after treatment, multiple primary tumors are more common than before. The diagnosis and treatment of synchronous multiple primary tumors is more complicated than that of single or metachronous multiple tumors, and patients also suffer more. Because of the different conditions of these patients, lack of large-scale clinical observation data, it is necessary for clinicians to make realistic decisions on the specific conditions of patients. It is a challenge for clinicians to apply the advances of modern medicine to the diagnosis and treatment of such patients so as to prolong their survival time and improve their quality of life. This report describes the survival of an advanced elderly patient with lung, prostate and bladder cancer after receiving targeted therapy-based comprehensive treatment.Keywords: advanced synchronous triple primary malignancieshttps://www.dovepress.com/clinical-treatment-of-advanced-synchronous-triple-primary-malignancies-peer-reviewed-article-OTTClinical TreatmentAdvanced Synchronous Triple Primary MalignanciesComprehensive TreatmentTargeted Therapy
collection DOAJ
language English
format Article
sources DOAJ
author Zhang Y
Ge Y
Wu X
Liu S
spellingShingle Zhang Y
Ge Y
Wu X
Liu S
Clinical treatment of advanced synchronous triple primary malignancies: comprehensive treatment based on targeted therapy
OncoTargets and Therapy
Clinical Treatment
Advanced Synchronous Triple Primary Malignancies
Comprehensive Treatment
Targeted Therapy
author_facet Zhang Y
Ge Y
Wu X
Liu S
author_sort Zhang Y
title Clinical treatment of advanced synchronous triple primary malignancies: comprehensive treatment based on targeted therapy
title_short Clinical treatment of advanced synchronous triple primary malignancies: comprehensive treatment based on targeted therapy
title_full Clinical treatment of advanced synchronous triple primary malignancies: comprehensive treatment based on targeted therapy
title_fullStr Clinical treatment of advanced synchronous triple primary malignancies: comprehensive treatment based on targeted therapy
title_full_unstemmed Clinical treatment of advanced synchronous triple primary malignancies: comprehensive treatment based on targeted therapy
title_sort clinical treatment of advanced synchronous triple primary malignancies: comprehensive treatment based on targeted therapy
publisher Dove Medical Press
series OncoTargets and Therapy
issn 1178-6930
publishDate 2019-04-01
description Ying Zhang, Yunjie Ge, Xiaohui Wu, Shuangmei LiuDepartment of Internal Medicine, Municipal Hospital, Qingdao, Shandong, People’s Republic of ChinaAbstract: The prevalence of cancer remains high. With the improvement of diagnosis and treatment level and the increase of cancer survivors after treatment, multiple primary tumors are more common than before. The diagnosis and treatment of synchronous multiple primary tumors is more complicated than that of single or metachronous multiple tumors, and patients also suffer more. Because of the different conditions of these patients, lack of large-scale clinical observation data, it is necessary for clinicians to make realistic decisions on the specific conditions of patients. It is a challenge for clinicians to apply the advances of modern medicine to the diagnosis and treatment of such patients so as to prolong their survival time and improve their quality of life. This report describes the survival of an advanced elderly patient with lung, prostate and bladder cancer after receiving targeted therapy-based comprehensive treatment.Keywords: advanced synchronous triple primary malignancies
topic Clinical Treatment
Advanced Synchronous Triple Primary Malignancies
Comprehensive Treatment
Targeted Therapy
url https://www.dovepress.com/clinical-treatment-of-advanced-synchronous-triple-primary-malignancies-peer-reviewed-article-OTT
work_keys_str_mv AT zhangy clinicaltreatmentofadvancedsynchronoustripleprimarymalignanciescomprehensivetreatmentbasedontargetedtherapy
AT gey clinicaltreatmentofadvancedsynchronoustripleprimarymalignanciescomprehensivetreatmentbasedontargetedtherapy
AT wux clinicaltreatmentofadvancedsynchronoustripleprimarymalignanciescomprehensivetreatmentbasedontargetedtherapy
AT lius clinicaltreatmentofadvancedsynchronoustripleprimarymalignanciescomprehensivetreatmentbasedontargetedtherapy
_version_ 1725008991402065920